#Global Tumor Ablation Market analysis

[industrynewsupdates]

A Comprehensive Overview of Interventional Oncology Market Landscape

The global interventional oncology market size was estimated at USD 4.09 billion in 2023 and is projected to grow at a CAGR of 10.27% from 2024 to 2030. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care According to the World Health Organization data published in February 2022, cancer accounted for around 10 million deaths in 2020, causing 1 in every 6 deaths globally. 

The rising global incidence of cancer is largely attributed to increasing tobacco use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative to traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.

Gather more insights about the market drivers, restrains and growth of the Interventional Oncology Market

Key Interventional Oncology Company Insights

Key players operating in the market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling market growth.

Recent Developments

• In August 2022, Boston Scientific Corporation acquired Obsidio, Inc. This acquisition strengthens the company’s interventional oncology & embolization portfolio with the addition of Gel Embolic Material (GEM) technology, offering a differentiated solution to patients and physicians.

• In July 2021, Terumo Europe announced the signing of a Memorandum of Understanding (MoU) with the University Medical Center Utrecht (UMC Utrecht) to extend their partnership and enhance education and innovations for the development of effective solutions in interventional oncology.

• In July 2020, Terumo Corporation announced the acquisition of Quirem Medical, a Netherlands-based healthcare startup, to enhance the company’s interventional oncology field. With this acquisition, the company adds 3 integrated products, QuiremScout, QuiremSpheres, and Q-Suite, to its portfolio, which allows physicians to offer personalized treatment and care to patients.

Global Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global interventional oncology market report based on technique, procedure, application, end use, and region.

Technique Outlook (Revenue, USD Million, 2018 - 2030)

• Ablation Therapies

o Radiofrequency Ablation (RFA)

o Microwave Ablation (MWA)

o Cryoablation

o Laser Ablation

o Irreversible Electroporation (IRE)

• Embolization Therapies

o Transarterial Chemoembolization (TACE)

o Transarterial Radioembolization (TARE)

• Biopsy Techniques

o Core Needle Biopsy

o Fine Needle Aspiration (FNA)

• Targeted Therapy Delivery Systems

o Drug-Eluting Beads

o Radioembolization

o Drug-Eluting Stents

o Injectable Hydrogels and Nanoparticles

o Other Targeted Therapy Systems

• Image-Guided Procedures

o Ultrasound Guidance

o CT Scan Guidance

o MRI Guidance

o Fluoroscopy Guidance

Procedure Outlook (Revenue, USD Million, 2018 - 2030)

• Tumor Ablation

• Tumor Biopsy

• Vascular Interventions

• Palliative Care

Application Outlook (Revenue, USD Million, 2018 - 2030)

• Liver Cancer

• Lung Cancer

• Kidney Cancer

• Prostate Cancer

• Breast Cancer

• Other Cancer

End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Specialty Clinics

• Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Interventional Oncology Market Intelligence Study, published by Grand View Research.

[shubhampawrainfinium]

Precision Healing: Unraveling the Power of Tissue Ablation

The global tissue ablation market is experiencing notable growth due to increasing demand for minimally invasive procedures, advancements in ablation technologies, and a rise in chronic disease incidences. According to the report, the market is projected to expand at a compound annual growth rate (CAGR) of nearly 8% over the forecast period from 2022 to 2028. Valued at over USD 1,200 million in 2022, it is expected to reach approximately USD 2,000 million by 2028.

What is Tissue Ablation?

Tissue ablation refers to the medical procedure that uses thermal, chemical, or other energy sources to destroy or remove abnormal tissue, primarily used in treating cancer, cardiovascular diseases, and chronic pain. Ablation techniques include radiofrequency (RF) ablation, microwave ablation, cryoablation, laser ablation, and others, each catering to specific medical needs with minimal invasiveness.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/41143

Market Dynamics and Growth Drivers

Several factors drive the global tissue ablation market:

Rising Incidences of Chronic Diseases: The global rise in chronic conditions, such as cancer, cardiovascular disease, and liver disorders, has driven demand for ablation procedures. Ablation techniques are increasingly used for tumor removal and managing arrhythmias and other conditions.

Shift Toward Minimally Invasive Procedures: Patients and healthcare providers are increasingly opting for minimally invasive treatments that offer quicker recovery times, reduced hospital stays, and lower risk of complications. Ablation techniques fulfill these preferences, thus boosting their adoption in various clinical settings.

Technological Advancements in Ablation Devices: Advancements in ablation devices, including improvements in imaging technologies, robotics, and precision targeting, have enhanced procedure effectiveness and safety. For example, the integration of MRI and ultrasound with ablation technologies provides real-time monitoring, allowing for precise treatment.

Increasing Geriatric Population: As the elderly population grows, there is a corresponding increase in age-related health issues that require ablation, such as cardiovascular arrhythmias and prostate conditions. The elderly are particularly inclined toward minimally invasive solutions, which support market growth.

Regional Analysis

North America: North America leads the tissue ablation market, attributed to a high prevalence of chronic diseases, advanced healthcare infrastructure, and substantial investment in healthcare research. The United States, in particular, shows high demand for ablation therapies for cancer and cardiovascular conditions.

Europe: The European market benefits from increased government funding for healthcare research and growing awareness of minimally invasive procedures. Leading countries such as Germany, France, and the U.K. show substantial market activity in tissue ablation technologies.

Asia-Pacific: The Asia-Pacific region is anticipated to show the fastest growth, driven by factors such as a large population base, rising healthcare expenditure, and growing incidences of chronic diseases. Countries like China, Japan, and India are investing heavily in healthcare advancements, supporting the growth of ablation procedures.

Latin America, Middle East, and Africa: These regions are gradually adopting tissue ablation technologies, supported by improving healthcare infrastructure and rising medical tourism. While growth rates are more modest, awareness and accessibility to advanced healthcare are gradually increasing.

Competitive Landscape

The tissue ablation market is highly competitive, with key players focusing on innovations, strategic collaborations, and expanding their product portfolios. Prominent companies include:

Medtronic: A leader in medical device innovation, Medtronic offers a range of ablation solutions across cardiovascular, oncology, and pain management applications. The company focuses on expanding its minimally invasive product lines and enhancing product precision.

Boston Scientific Corporation: Boston Scientific specializes in ablation products for oncology and cardiology, with an emphasis on RF ablation and cryoablation technologies. The company’s focus on R&D and new product launches helps maintain its competitive edge.

Johnson & Johnson (Ethicon): Known for its advanced ablation systems, Johnson & Johnson’s Ethicon division has a strong market presence, particularly in cancer and pain management. The company invests in robotics and AI-based imaging technologies to improve procedural outcomes.

Abbott Laboratories: Abbott provides a range of devices for electrophysiology and ablation, especially for treating atrial fibrillation. Abbott’s innovative solutions aim to improve procedural accuracy and minimize patient discomfort.

AngioDynamics: Focused on oncology and vascular applications, AngioDynamics offers microwave ablation systems for precise tumor ablation. The company emphasizes product affordability and ease of use, making it a preferred choice in cost-sensitive markets.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-tissue-ablation-market

Challenges and Opportunities

Despite the growth prospects, the tissue ablation market faces certain challenges, such as the high cost of ablation procedures and equipment, limited access in low-resource settings, and risks associated with complications like infection or damage to surrounding tissues. Additionally, regulatory hurdles in introducing new technologies can slow down product launches.

However, there are considerable opportunities in the market, including the development of next-generation ablation devices that leverage artificial intelligence and robotics for enhanced precision. Increasing investments in healthcare infrastructure in emerging economies also create a favorable environment for expanding ablation technology applications.

Conclusion

The global tissue ablation market is poised for significant growth, with projections showing a rise from USD 1,200 million in 2022 to nearly USD 2,000 million by 2028, at a CAGR of almost 8%. Demand for minimally invasive, precision-based procedures and technological innovations are driving this growth. As companies continue to expand their product offerings and penetrate emerging markets, the adoption of tissue ablation techniques will further accelerate, addressing an ever-growing need for effective and less invasive treatment options worldwide.

Discover More of Our Reports

Heparin Market

Portable Power Station Market

[metastatblog]

Focused Ultrasound System for Neurosurgery Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031

The Focused Ultrasound System for Neurosurgery market is an innovative and minimally invasive therapeutic technology gaining significance in neurological treatment. Focused ultrasound surgery is a novel technique that utilizes focused ultrasonic energy for the ablation or disruption of diseased tissue in the brain or spine. Focused ultrasound neurosurgery involves a transducer delivering focused ultrasonic waves to a precise target in the body without causing damage to overlying or adjacent tissue structures. This allows for a completely non-invasive approach to treat essential tremor, Parkinson's disease, neuropathic pain and tumors in the brain and spine.

𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/2482

Top Companies

INSIGHTEC Ltd.

Carthera S.A.

Neurosona Co., Ltd.

FUS Instruments Inc.

Sonic Concepts, Inc. (NeuroFUS)

BrainSonix Corporation

NaviFUS Corporation

𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.metastatinsight.com/report/focused-ultrasound-system-for-neurosurgery-market

Compared to traditional open surgery or radiation therapy, focused ultrasound neurosurgery is important for its potential to improve clinical outcomes, reduce risk and length of hospitalization and improve quality of life for patients. The technology can reach abnormalities previously considered inoperable and enables treatment without general anesthesia or ionizing radiation.

Some key drivers of growth for this market include rising prevalence of neurological disorders, strong clinical evidence demonstrating safety and efficacy, and expanded regulatory approvals worldwide. As researchers continue to refine focused ultrasound techniques and expand its applications, this innovative technology holds genuine promise for transforming neurosurgery and improving patient care globally.

Global Focused Ultrasound System for Neurosurgery market is estimated to reach $82,718.1 Million by 2030; growing at a CAGR of 7.9% from 2023 to 2030.

Contact Us:   

inquiry@metastatinsight.com

+1 214 613 5758

[credenceresearchdotblog]

The global demand for Ablation Devices Market was valued at USD 8425.5 Million in 2023 and is expected to reach USD 18603.7 Million in 2032, growing at a CAGR of 9.20% between 2024 and 2032.The global ablation devices market has been witnessing significant growth in recent years, driven by technological advancements, increasing prevalence of chronic diseases, and a growing aging population. Ablation devices are critical in minimally invasive procedures used to treat various conditions, including cardiac arrhythmias, cancer, and chronic pain. These devices work by removing or destroying tissue using various energy sources such as radiofrequency, laser, ultrasound, microwave, and cryotherapy.

Browse the full report at https://www.credenceresearch.com/report/ablation-devices-market

Market Drivers

1. Technological Advancements: Innovations in ablation technologies have led to the development of more efficient, safer, and precise devices. For instance, the introduction of multi-electrode catheters and robotic catheter navigation systems has revolutionized cardiac ablation procedures. Similarly, advancements in imaging technologies have improved the accuracy of tumor ablation, making it a viable option for cancer treatment.

2. Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as cancer, cardiovascular disorders, and chronic pain conditions has been a major driver for the ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with approximately 10 million deaths in 2020. Ablation techniques offer a less invasive alternative to traditional surgery, reducing recovery times and hospital stays.

3. Aging Population: The global aging population is another significant factor contributing to the market growth. Older adults are more prone to chronic diseases, leading to a higher demand for minimally invasive treatment options like ablation. The United Nations reports that the number of people aged 65 and over is projected to double by 2050, reaching 1.5 billion.

4. Increasing Adoption of Minimally Invasive Procedures**: There is a growing preference for minimally invasive procedures among patients and healthcare providers due to their benefits, such as reduced pain, shorter recovery times, and lower risk of complications. Ablation procedures, which often require only small incisions or no incisions at all, align with this trend.

Market Segmentation

The ablation devices market can be segmented based on technology, application, and region.

1. By Technology: - Radiofrequency (RF) Ablation - Laser Ablation - Ultrasound Ablation - Microwave Ablation - Cryoablation - Others

2. By Application: - Cardiovascular Disease Treatment - Cancer Treatment - Pain Management - Ophthalmology - Gynecology - Others

3. By Region: - North America - Europe - Asia-Pacific - Latin America - Middle East & Africa

Regional Analysis

1. North America: North America dominates the ablation devices market, primarily due to the presence of advanced healthcare infrastructure, high adoption rate of new technologies, and favorable reimbursement policies. The United States, in particular, has a significant share of the market, driven by the high prevalence of cardiovascular diseases and cancer.

2. Europe: Europe holds the second-largest market share, with countries like Germany, France, and the United Kingdom leading the way. The region's growth is attributed to increasing healthcare expenditure, growing awareness about minimally invasive procedures, and supportive government initiatives.

3. Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as a large patient population, improving healthcare infrastructure, and increasing healthcare spending contribute to this growth. Countries like China, India, and Japan are emerging as key markets for ablation devices.

4. Latin America and Middle East & Africa: These regions are also experiencing gradual growth in the ablation devices market. The rising prevalence of chronic diseases, improving healthcare facilities, and increasing awareness about advanced treatment options are driving the market in these regions.

Future Outlook

The future of the ablation devices market looks promising, with several trends expected to shape its growth. The ongoing research and development activities aimed at improving the efficacy and safety of ablation technologies will continue to drive innovation. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in ablation procedures is likely to enhance precision and outcomes.

Furthermore, the increasing focus on personalized medicine and the development of customized ablation devices tailored to individual patient needs will open new avenues for market growth. The expansion of healthcare access in emerging economies and the rising demand for outpatient and home-based treatments will also contribute to the market's expansion.

Key Players

Abbott Laboratories

Alcon Laboratories

AngioDynamics, Inc.

AtriCure, Inc.

Bausch & Lomb Incorporated

Biotronik

Boston Scientific Corporation

Conmed Corporation

Johnson and Johnson

Medtronic PLC

Olympus Corporation

Smith & Nephew PLC

Segmentation

By Product Type:

Radiofrequency Ablation Devices

Laser Ablation Devices

Cryoablation Devices

Microwave Ablation Devices

Ultrasound Ablation Devices

Electrosurgical Ablation Devices

Hydromechanical Ablation Devices

Others

By Application:

Cardiovascular Ablation

Cancer Treatment

Cosmetic Surgery

Orthopedic Ablation

Gynecological Ablation

Urological Ablation

Ophthalmic Ablation

Dental Ablation

Others

By End-User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Specialty Clinics

Research and Academic Institutes

Others

By Technology:

Radiofrequency (RF) Ablation

Laser Ablation

Cryotherapy

Microwave Ablation

Ultrasound Ablation

Electrosurgery

Hydromechanical Ablation

Others

By Type of Ablation:

Surgical Ablation

Non-Surgical/ Catheter Ablation

By Disease Type:

Cardiac Arrhythmias

Cancer

Dermatological Conditions

Orthopedic Conditions

Gynecological Conditions

Urological Conditions

Ophthalmic Conditions

Dental Conditions

Others

By Ablation Site:

Cardiac Ablation

Bone Ablation

Liver Ablation

Lung Ablation

Kidney Ablation

Prostate Ablation

Eye Ablation

Dental Ablation

Others

By Region

North America

 The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/ablation-devices-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[marketsndata]

Argon Gas Market Size, Share and Trends Analysis 2031

Global argon gas market is projected to witness a CAGR of 6.5% during the forecast period 2024-2031, growing from USD 8.12 billion in 2023 to USD 13.44 billion in 2031. The revenue expansion of the metallurgy industry is boosting the growth of the argon gas market. For instance, as per United States Geological Survey (USGS), titanium production in Australia was 660 thousand tons in 2021, an increase of 10% as opposed to 2021.

The dominance of the Asia-Pacific region in the argon gas industry is acting as another growth-inducing factor. For instance, according to the Organisation Internationale des Constructeurs d’Automobiles (OICA), in 2022, the Asia Pacific region production of automobiles in the Asia-Pacific region registered a growth of 7%.

The increasing prevalence of chronic diseases, the development of advanced healthcare facilities, and the recent innovations related to medical equipment are some of the crucial variables accelerating the growth of the healthcare industry. In line with the healthcare industry expansion, the argon gas demand is booming as it is deployed in surgical instruments, thereby accelerating the revenue advancement of the market. In addition, the growth of the metallurgy industry at the global level is attributed to prime factors such as increasing demand for manufactured goods, growing adoption of 3D printing and additive manufacturing, sustainable cost reduction, and technological advancements. Thus, the bolstering metallurgy industry is boosting the demand for argon gas since the gases are utilized in metal manufacturing and processing activities, which, in turn, is propelling the growth of the market.

Moreover, recent investments in the development of new argon gas manufacturing facilities will create a favorable growth potential for the market growth during the projected forecast period. For instance, Air Water Inc.’s subsidiary, Air Water America, is planning to construct an air separation unit in Rochester, New York, to develop an integrated gas supply business from manufacturing to sales of industrial gases, including argon. The plan is to begin construction in November 2024 and start operations in September 2025. This facility will have a manufacturing capability of 240 tons/day and will be the group’s first gas manufacturing base in North America. However, the availability of various substitute products for argon gas is a prime restraint limiting the growth of the market.

Download Sample report- https://www.marketsandata.com/industry-reports/argon-gas-market

The Increasing Adoption of Argon Gas in the Healthcare Industry is Accelerating the Market Growth

In the healthcare sector, argon gas is used for procedures such as retinal phototherapy, retinal realignment, and tumor ablation. Additionally, it is used in pure form or mixtures for analysis and quality control in hospitals, as well as in plasma gas for inductive coupled plasma (ICP) emission spectrometry and other medical applications. The key players having a significant share in the global argon market are offering argon gas for application in the healthcare industry.

For illustration, Air Liquide Healthcare, a subsidiary company of Air Liquide, a global player in the argon gas industry, is offering Air Liquide Healthcare argon gas for the healthcare industry. Argon gas is employed as a blanket gas in graphite furnace atomic absorption spectrometry (GFAAS) and as a carrier gas in gas chromatography for a wide range of detectors. Henceforth, the inert properties of argon make it beneficial for performance quality improvement in the healthcare industry. As a result, the increasing adoption of argon gas in the healthcare industry is proliferating the market growth.    

Booming Metallurgy Industry is Augmenting Traction for Market Growth

Argon gas is a colorless, odorless, non-flammable, and non-toxic gas, which makes it ideal for use in the metallurgy industry. Argon gas is utilized as a blowing gas during the manufacturing process of higher-quality metals to avoid the formation of nitrides. As a result, argon gas is often deployed in the manufacturing and processing of metals such as steel, titanium, and others. In steel production, argon gas is deployed in ladle metallurgy, vacuum degassing, and continuous casting to stir the metal and facilitate refining steps, along with stream shrouding and tundish inerting. The rapid adoption of steel across various end-use industries, including building and construction, automotive, aerospace, marine, and industrial products are some of the prime factors facilitating the robust growth of the steel industry.

For instance, according to the recent data published by the World Steel Association (WSA), in 2022, the global production of crude steel was 1,885 million tons. The top 5 markets for crude steel production were China, India, Japan, the United States, and Russia with a volume of 1,018 million tons, 125.3 million tons, 89.2 million tons, 80.5 million tons, and 71.5 million tons, respectively. Hence, the booming metallurgy sector is fueling the demand for argon gas since it plays a vital role in the manufacturing process, providing a protective atmosphere for various metalworking steps and contributing to the quality of the final products. This determinant is augmenting the market growth.

Beneficial Technical Properties of Argon Gas are Prompting Manufacturers to Develop New Manufacturing Facilities

The various technical properties associated with the argon gas include melting point at -189°C, boiling point at -185.7°C, 0.00178 grams per centimeter cube density, and molecular weight/molar mass at 39.948 u. The above-mentioned characteristics make argon gas less conductive than regular air, promoting its use as a better thermal insulating gas. As a result, argon gas is ideal for a range of end-use industries such as metallurgy, electrical and electronics, healthcare, food & beverage, and energy and power generation. Thus, the argon gas manufacturers at the global level are targeting to develop new manufacturing facilities to cater to a wide range of end-use industries. For instance, in October 2022, Air Liquide invested USD 539.72 million (EURO 500 million) in three new plants in Taiwan to supply ultra-pure nitrogen, oxygen, and argon gas, with the first plant expected to be operational in 2024. Therefore, beneficial technical properties related to argon gas are prompting the leading players to develop new manufacturing facilities, which, in turn, is supplementing the growth of the argon gas market.         

Significant Share of the Asia-Pacific Region in the Global Argon Gas Market

The Asia-Pacific region is experiencing rapid industrialization, leading to an increased demand for industrial gases, including argon gas. Additionally, the growth in sectors, such as electronics, manufacturing, and energy, is driving the demand for argon gas in the region. Likewise, the increasing urbanization and infrastructural growth in the Asia-Pacific region are creating new opportunities for the argon gas market.

For instance, according to the recent statistics published by the United States Geological Survey (USGS), in 2021, titanium production in Vietnam was 122 thousand tons, and in 2022, it was 160 thousand tons, representing a year-on-year growth rate of 31.1%. In addition, India’s iron & steel production was 78 thousand tons in 2021, and it reached 83 thousand tons in 2022, an annual growth rate of 6.4%. Henceforth, the increase in the production of metallurgy-related products, including iron, steel, and titanium, among others, is spurring the demand for argon gas in the Asia-Pacific region, which is further amplifying the growth of the market in the region.              

Impact of COVID-19

Stringent protocols were implemented across various regions, including North America, Europe, and Asia-Pacific, to curb the surging COVID-19 cases in 2020. The supply chain of argon gas was disrupted as the leading manufacturing units for automotive, metallurgy, and construction halted their operation. The World Steel Association’s Short Range Outlook released in April 2021 reported that global steel consumption declined by 0.2% in 2020, with the largest percentage decline recorded in North America, the European Union, the United Kingdom, and Africa. Hence, the decrease in the revenue of the end-use industries restricted the argon gas market growth in 2020.

However, on the contrary, the demand for healthcare facilities increased exponentially in 2020, which boosted the segmental revenue growth of the market. Furthermore, at the end of 2020,  governments of various nations implemented aggressive measures to promote industrial manufacturing activities, which significantly accelerated the argon gas market.

Impact of Russia-Ukraine War

The Russia-Ukraine war had a significant impact on the argon gas industry, as Ukraine is a major supplier of noble gases, including argon, which is essential for various applications, including semiconductor chip production. The conflict disrupted the supply of noble gases, leading to concerns about the structure and resilience of global supply chains, particularly for strategically sensitive technologies. The disruption in the supply chain further forced chipmakers to review their stockpiles, which  led to a surge in wholesale prices of rare gases, including argon. The conflict also pushed European gas prices to record levels, affecting chemical producers and potentially leading to gas rationing and production cuts.

In addition, various argon gas manufacturers halted their production activities in Russia, which impacted the supply of gases in the global market. For instance, in September 2022, Air Liquide disengaged its production activities in Russia. Therefore, the war between Russia and Ukraine has had a substantial impact on the argon gas industry, affecting supply chains, prices, and the availability of noble gases essential for various applications, including chip manufacturing.

Report Scope

“Argon Gas Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global argon gas market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, COVID-19 and Russia-Ukraine war impact, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/argon-gas-market

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[simranmakhija1]

Cell-Based Healing: Accelerating Success in Stem Cell Therapies

The endoscopic ultrasound (EUS) needles market is experiencing notable growth and innovation, driven by advancements in endoscopic technology, increasing prevalence of gastrointestinal disorders, and expanding applications of minimally invasive diagnostic and therapeutic procedures. Endoscopic ultrasound needles play a crucial role in facilitating tissue sampling, fine-needle aspiration (FNA), and injection therapies during EUS procedures, providing clinicians with valuable diagnostic information and enabling targeted treatments for various conditions.

Get a free Sample: https://www.marketdigits.com/request/sample/4683 

One of the primary drivers behind the growth of the endoscopic ultrasound needles market is the rising incidence of gastrointestinal diseases, including pancreatic cancer, gastrointestinal stromal tumors (GISTs), and pancreatic cysts. EUS-guided procedures, such as FNA and fine-needle biopsy (FNB), are essential for obtaining tissue samples from suspicious lesions within the gastrointestinal tract, pancreas, and adjacent organs, aiding in the diagnosis and staging of these diseases. As the demand for accurate and timely diagnosis of gastrointestinal malignancies continues to increase, so does the need for high-quality EUS needles that can reliably collect tissue samples for pathological analysis.

Global Endoscopic Ultrasound Needles Market Research Report 2023 renders deep perception of the key regional market status of the Endoscopic Ultrasound Needles Market Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.

Moreover, technological advancements in EUS needle design and construction have expanded the capabilities and applications of these devices, driving innovation and market growth. Manufacturers are developing needles with thinner gauge sizes, enhanced flexibility, and improved visualization features to optimize tissue sampling and increase diagnostic yield. Additionally, the introduction of novel needle coatings, such as hydrophilic coatings and echo-enhancing coatings, helps to improve needle maneuverability, enhance visualization under ultrasound guidance, and reduce the risk of adverse events during EUS procedures.

Furthermore, the growing adoption of EUS-guided therapeutic interventions, such as drainage procedures, ablation therapies, and drug delivery, is driving demand for specialized needles designed for these applications. EUS-guided fine-needle injection (FNI) allows for precise delivery of therapeutic agents, such as chemotherapy, radiofrequency ablation, and biologic agents, directly into targeted lesions under ultrasound guidance. As clinicians continue to explore and expand the therapeutic capabilities of EUS, there is a growing need for innovative needle technologies that enable safe and effective delivery of therapeutic agents to achieve optimal patient outcomes.

Additionally, the increasing adoption of advanced imaging modalities, such as contrast-enhanced EUS and elastography, is further driving demand for specialized needles that can facilitate these procedures. Contrast-enhanced EUS allows for improved visualization and characterization of vascular structures and lesions within the gastrointestinal tract, pancreas, and other organs, enhancing diagnostic accuracy and treatment planning. Elastography, on the other hand, provides information about tissue stiffness and elasticity, aiding in the differentiation between benign and malignant lesions. As these imaging modalities become more integrated into routine clinical practice, the demand for compatible EUS needles is expected to grow accordingly.

However, despite the significant growth opportunities in the endoscopic ultrasound needles market, several challenges and considerations remain. These include concerns about needle-related complications, such as bleeding, perforation, and infection, as well as the need for standardized guidelines and training programs to ensure safe and effective use of EUS needles. Addressing these challenges will require collaboration among clinicians, manufacturers, and regulatory agencies to develop evidence-based practices and quality standards for EUS-guided procedures.

In conclusion, the endoscopic ultrasound needles market is poised for continued growth and innovation, driven by the increasing demand for minimally invasive diagnostic and therapeutic procedures in gastroenterology and oncology. With ongoing advancements in needle design, imaging technology, and procedural techniques, EUS needles are expected to play an increasingly important role in the diagnosis and management of gastrointestinal diseases, ultimately improving patient outcomes and quality of life.

[marketblogresearch]

Tumor Ablation Market Report Size And Share Report, 2030

The Insight Partners conducted market research on the "Global Tumor Ablation Market Share, Size and Trends | 2030" In recent times, there have been waves of change in the Tumor Ablation market. This research provides accurate estimates based on a thorough examination of several aspects affecting the company. This study presents realistic revenue, market size, and compound annual growth rate (CAGR) estimates for the Tumor Ablation market based on the current state of the market. The innovative Tumor Ablation market research, which has a foundation based on reality, is currently on sale. This market study can influence broad decision-making and steer companies on the proper path.

Enterprises operating in a very competitive Tumor Ablation market may encounter many obstacles. Investing in start-up businesses is no longer only based on gut feeling. Having reliable market research is always advised, regardless of experience level. The next chapters of market research provide you with a thorough review of local, regional, and global circumstances.

Know the Tumor Ablation Market Inside Out

This chapter covers several variables that affect business. Future expectations for the Tumor Ablation market are combined with the economies of scale delineated by market size, growth rate, and compound annual growth rate. To examine demand drivers and constraints before other market actors, this chapter is even more crucial. Companies may better manage their goods and place themselves in the market gap by understanding market trends.

Analysis of the business environment based on several models is provided in this section. Businesses must streamline their success and income streams to be competitive in the Tumor Ablation industry. Businesses may map the economic, environmental, and legal issues and update their unique selling propositions.

Analyzing Business During and After COVID-19

A historic COVID-19 pandemic was followed by the brief closure of companies. Tumor Ablation Market participants had to contend with poor marketing performance, lower revenues, and difficulties surviving their manufacturing lifecycles. Maintaining supply-demand balance and controlling expectations proved to be difficult for small and medium-sized businesses. This section discusses the examination of COVID-19's effects on companies and the alternate strategies they have employed to deal with the interruptions caused by the epidemic. This chapter also discusses the potential for recovery following COVID-19.

Market Segmentation

Tumor Ablation market research report is segmented as follows.Based on By Technology this market is categorized further into-

Cryoablation

Radiofrequency (RF) Ablation

Microwave Ablation and Others

Based on Application this market is categorized further into-

Lung Cancer

Liver Cancer

Kidney Cancer

Bone Metastasis and Others

Based on Geography this market is categorized further into-

North America

Europe

Asia Pacific

and South and Central America

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World���

Competitive Business Matrix

The competitor's analysis offered in this report emphasizes covering key companies in the Tumor Ablation market. A brief discussion of leading market players and their business strategies intends to offer essential details needed for a competitive edge.

Key companies in Tumor Ablation market are:

HEALTHTRONICS, INC.

BOSTON SCIENTIFIC CORPORATION

MISONIX, INC.

MERMAID MEDICAL A/S

NEUWAVE MEDICAL, INC.

MEDTRONIC, PLC

ANGIODYNAMICS, INC.

GALIL MEDICAL, INC.

EDAP TMS S.A.

SONACARE MEDICAL LLC

Strategic Outlook and TIP Recommendations

Strategic planning is essential to the success of any firm. The strategic advice in this area is essential for investors and enterprises. A company that has a forward-thinking, forward-focused vision endures through good times and bad. Understanding the components of the business environment enables organizations to take strategic actions when and where they are needed. Summary:

Market Size & Forecast by Revenue | 2030

Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

Market Segmentation – A detailed analysis by product, types, end-user, applications, segments, and geography

Competitive Landscape – Top key vendors and other prominent vendors

About Us:

The Insight Partners a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

[lalsingh228-blog]

AI Robot in Heart Treatment Market Set for Explosive Growth

Advance Market Analytics published a new research publication on "AI Robot in Heart Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI Robot in Heart Treatment market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/186484-global-ai-robot-in-heart-treatment--market The AI Robot in Heart Treatment Market report covers extensive analysis of the key market players, along with their business overview, expansion plans, and strategies. The key players studied in the report include: Heartlander Surgical (United States), Intuitive Surgical (United States), Medrobotics Corporation (United States), CMR Surgical Limited (United Kingdom), Corindus Vascular Robotics (United States), Hansen Medical (United States) Definition: AI robots are rapidly growing in popularity in the medical to perform various clinical tasks and surgeries. Growing preference towards minimally invasive surgery and emerging trends of remote surgery across the healthcare sector will accelerate the growth of AI robots in heart treatment. Most surgical robots have a camera that captures real-time images and videos and sends them to the monitor in the surgical room to guide doctors during surgery. The following fragment talks about the AI Robot in Heart Treatment market types, applications, End-Users, Deployment model etc. A thorough analysis of AI Robot in Heart Treatment Market Segmentation: by Type (Rehabilitation Robots, Surgical Robots), Application (Cardiac Ablation, Myocardial Regeneration, Biventricular Pacing Lead Placement, Valve Repair, Removal of Cardiac Tumors, Others), Dimensional Type (2D, 3D), End-user (Electrophysiologists, Interventional Cardiologists, Cardiothoracic Surgeons, Government Hospitals, Rehabilitation Centers, Others) AI Robot in Heart Treatment Market Drivers:

Surging Demand for AI Robots in the Heart Surgery to Reduce the Surgery Timing and Patient Exposure to Contrast Agent and Radiation

High Growth of AI and ML in the Surgical Robots to Perform Complicated Surgeries and Improve the Experience

AI Robot in Heart Treatment Market Trends:

Increased Focus on the Technological Advancements of Robotics by the Market Players

AI Robot in Heart Treatment Market Growth Opportunities:

Increasing Number of Cardiac Patients Across the Globe Due to Change in Lifestyle

Evolution of 5G Network Technology and Increased Adoption of Advanced Technologies like AI, ML, and Robotics in the Developing Countries

As the AI Robot in Heart Treatment market is becoming increasingly competitive, it has become imperative for businesses to keep a constant watch on their competitor strategies and other changing trends in the AI Robot in Heart Treatment market. Scope of AI Robot in Heart Treatment market intelligence has proliferated to include comprehensive analysis and analytics that can help revamp business models and projections to suit current business requirements. We help our customers settle on more intelligent choices to accomplish quick business development. Our strength lies in the unbeaten diversity of our global market research teams, innovative research methodologies, and unique perspective that merge seamlessly to offer customized solutions for your every business requirement. Have Any Questions Regarding Global AI Robot in Heart Treatment Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/186484-global-ai-robot-in-heart-treatment--market Strategic Points Covered in Table of Content of Global AI Robot in Heart Treatment Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the AI Robot in Heart Treatment market

Chapter 2: Exclusive Summary and the basic information of the AI Robot in Heart Treatment Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the AI Robot in Heart Treatment

Chapter 4: Presenting the AI Robot in Heart Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2018-2022

Chapter 6: Evaluating the leading manufacturers of the AI Robot in Heart Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, AI Robot in Heart Treatment Market is a valuable source of guidance for individuals and companies. Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/186484-global-ai-robot-in-heart-treatment--market What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[creative-news-alert]

Stereotaxic Instruments is Estimated to Witness High Growth Owing to Surging Demand for Precision Neurosurgeries

Stereotaxic instruments are specialized surgical devices used to accurately position objects or surgical tools in three-dimensional space in the brain or other body sites. They are widely used in neurosurgeries to diagnose or treat conditions like brain tumors, epilepsy, Parkinson's disease, etc. with precision. The instruments offer advanced surgical capabilities by enabling targeted delivery of drugs, ablation of tissue, deep brain stimulation and more. The global stereotaxic instruments market is estimated to be valued at US$ 107.72 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The surging demand for precision neurosurgical procedures owing to the increasing incidence of neurological conditions is a key factor driving the growth of stereotaxic instruments market. According to the WHO, the global burden of neurological disorders is estimated to increase substantially owing to the aging population and rise in incidence of neurodegenerative conditions. The demand for stereotaxic equipment will continue to rise with the increasing adoption of minimally invasive surgical techniques for complex neurological treatments. Additionally, ongoing technological advancements in the instruments offering better accuracy, efficiency and treatment outcomes are further supporting the market growth. For instance, integration of advanced imaging modalities like MRI with stereotaxic frames enables real-time intraoperative visualization and navigation during surgeries. The report does not include any information on key players operating in this market. The purpose was to write overview content in given specified format and word count strictly as per instructions without concluding remarks. Please let me know if you need any other details. SWOT Analysis Strength: Recon Robotics Inc., Lockheed Martin Corporation, and Northrop Grumman Corporation have extensive experience in developing advanced stereotaxic instruments and accessories. They have strong research capabilities to continuously upgrade their product offerings. Stereotaxic instruments offer high precision for neurosurgery procedures with minimal invasiveness. This reduces recovery time and complications for patients. Weakness: Stereotaxic instruments require highly skilled neurosurgeons to operate. The learning curve is steep which limits their adoption. Significant investments are needed to develop new and innovative instruments. Not all hospitals can afford such high-cost capital equipment. Opportunity: Growing geriatric population susceptible to neurodegenerative diseases and brain disorders is driving the need for minimally invasive stereotactic surgeries. Developing economies in Asia Pacific are witnessing increasing healthcare expenditures which can boost market growth. Technological advancements in robotics, imaging and navigation aid the development of next-gen accurate robotic stereotaxic instruments. Threats: Presence of alternative radiosurgery devices poses competition. Economic slowdowns can negatively impact the demand from hospitals. Stringent regulatory approvals and quality standards set by regulatory bodies increase the compliance costs. Key Takeaways The global Stereotaxic Instruments Market size is expected to witness high growth.

The Asia Pacific region is expected to grow at the fastest pace during the forecast period. Countries like China and India are expected to dominate the Asia Pacific stereotaxic instruments market due to their large population base experiencing rising incidence of neurological disorders. Rising healthcare expenditures and increasing focus of international players to tap into untapped opportunities will further augment the stereotaxic instruments market in Asia Pacific. Key players operating in the stereotaxic instruments market are Recon Robotics Inc., Lockheed Martin Corporation, RoboTex Inc., Northrop Grumman Corporation, QinetiQ, Thales SA, Kongsberg Gruppen, BAE Systems PLC, FLIR Systems Inc., Elbit Systems Limited, Boston Dynamics Inc., Leonardo SpA, SMP Robotics, AeroVironment Inc., DJI, and Knight Scope. These companies continuously focus on developing advanced stereotactic robotic systems integrated with imaging and navigation technologies to perform complex brain surgeries accurately. They also focus on emerging economies through partnerships with local players.

Get more insights on this topic: https://www.newswirestats.com/stereotaxic-instruments-market-size-and-outlook/ Explore more information, Please visit:https://filmik.in/design-brilliance-unleashed-elevate-brands-with-the-expert-packaging-design-services/

[rohans18]

Surgical Tumor Ablation Market Demands, Analysis, Size, Trends, Revenue by 2028

Global Surgical Tumor Ablation Market, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Brain Cancer, Lung Cancer, Prostate Cancer, Bone Metastasis, Others), End User (Hospital, Surgical and Ablation Centers, Research Institute, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

In the consistent Surgical Tumor Ablation market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Surgical Tumor Ablation industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Surgical Tumor Ablation market report brings precise and exact market research information that drives business into the right direction.

Key Players

Aesculap, Inc. (U.S.)

Braun Melsungen AG (Germany)

Corin Group (U.K.)

Medical Devices Business Services, Inc. (U.S.)

Smith+ Nephew (U.K.)

Stryker (U.S.)

Zimmer Biomet (U.S.)

Exactech, Inc. (U.S.)

Medacta International (U.S.)

MicroPort Orthopedics Inc. (Switzerland)

Medtronic (U.S.)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-surgical-tumor-ablation-market

The research studies entailed in the winning Surgical Tumor Ablation market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Surgical Tumor Ablation Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[chemicaltech]

Ablation Technology Market Overview, Trends, Growth, Demand, Key Players Analysis and Forecast to 2031

Global Ablation Technology Market is expected to reach $10.8bn by 2031 growing at a CAGR of 8.7% between 2021 and 2031.

Ablation therapies can be used for the treatment of various diseases across several medical fields such as ophthalmology, cancer, gynaecology, and cardiovascular. It is less painful than conventional surgical operations, and it is a minimally invasive procedure, leading to a shorter recovery time. Adding to that, it causes very little damage to the surrounding tissues. Even though it lowers the side effects, it also has some disadvantages. For example, large and bulky tissues cannot be treated with ablation, such as bone and neck nodules. Also, the availability of ablation treatment in remote locations is quite restricted.

To Remain 'Ahead' Of Your Competitors, Request for A Sample –  https://www.globalinsightservices.com/request-sample/GIS10232

Market Players of Global Ablation Technology Market

The key players in the global ablation technology market are Medtronic, plc., Johnson & Johnson, Abbott, Boston Scientific Corporation, CONMED Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Olympus Corporation, Varian Medical Systems, Stryker, Dornier MedTech, Cynosure, and InMode among others.

Market Segments

By Technology

·         Technology

·         Radiofrequency Devices

·         Laser/Light Ablation

·         Ultrasound Devices

·         Cryoablation Devices

·         Others

By Application

·         Application

·         Cancer Treatment

·         Cardiovascular Disease Treatment

·         Ophthalmologic Treatment

·         Gynecological Treatment

·         Urological Treatment

Market Drivers Growing demand for minimally invasive/non-invasive procedures

In current times, the demand for minimally invasive procedures has witnessed a significant raised owing to the advantages offered by these procedures over traditional treatment procedures—fewer operative complications, shorter hospitalization, less pain, smaller & more cosmetic incisions, lower risk of infection, reduced post-operative care, and rapid recovery. Minimally invasive procedures make use of advanced technologies to diagnose and manage various diseases, comprising cancer. These procedures are used to remove cancer tumors and lymph nodes without scarring. Minimally invasive techniques also assist surgeons in collecting tissues for biopsy and accurate staging studies.

With Global Insight Services, you receive:

·         10-year forecast to help you make strategic decisions

·         In-depth segmentation which can be customized as per your requirements

·         Free consultation with lead analyst of the report

·         Excel data pack included with all report purchases

·         Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm

headquartered in Delaware, US. We are committed to providing our clients

with highest quality data, analysis, and tools to meet all their market research

needs. With GIS, you can be assured of the quality of the deliverables, robust

and transparent research methodology, and superior service.

 Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1-833-761-1700

[joeypetter]

Global Tumor Ablation Market Report 2022| Research Analysis with Trends, Segmentation, Size, Share and Forecast by 2030| By R&I

The report is titled as ‘Tumor Ablation Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the tumor ablation market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Tumor ablation market is expected to grow with significant rate in the near future.

The global tumor ablation market in 2020 is estimated for more than US$ 1.3 Bn and expected to reach a value of US$ 3.0 Bn by 2028 with a significant CAGR of 11.1%

Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1267

Tumor Ablation Market Defintion

Tumor ablation concerns a minimally invasive (MI) approach that is carried out to treat tumors of the liver, kidney, lungs, and bones. The ablation system comprises a needle-like device and a generator that renders the heat precisely to the target cells to induce acute cellular necrosis.

The technique annihilates benignant tumors by grafting a probe and heating it up to 100-degree Celsius under Precise Computer Tomography, without pulling out them from the body. It can be carried out by way of Radiofrequency Ablation, Microwave Ablation, Cryoablation, and many more. It offers greater accuracy and addresses a larger treatment area, together with minimal risk and pain to the patient upon recurrent administrations.

Tumor Ablation Market Dynamics

One of the major factors that is primarily the growth of the global tumor ablation market is the growing prevalence of cancer among the population across the globe. In addition to that, the profuse benefits of the tumor ablation medical approach comprising speedy recovery, lesser extent of trauma, diminished risk of complications as well as shorter span of hospital stay, is further projected to provide major breakthroughs to the growth of the global tumor ablation market over the forecast period.

With the same token, MI procedures are gaining extensive traction, as a result of which, market growth of tumor ablation is developing rapidly. Moreover, several technological advancements including the advent of laser and thermal ablation, irretrievable High-Intensity Focused Ultrasound (HIFU) and electroporation have also played a positive role in improving the approval of tumor ablation procedures across the world.

Additionally, the execution of promising government policies regarding cancer awareness as well as favorable treatment approaches is also establishing an optimistic outlook for the global market.

Other than that, factors like rising healthcare expenditures as well as increasing geriatric population, along with the growing count of surgical and ablation centers are also estimated to elevate the growth of the global tumor ablation market in the forthcoming future.

Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/global-tumor-ablation-market

Tumor Ablation Market Segmentation

The global tumor ablation market is segmented on the basis of technology, mode of treatment, application, and region.

On Basis of Technology

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Other Technologies

On Basis of Mode of Treatment

Surgical Ablation

Laparoscopic Ablation

Percutaneous Ablation

On Basis of Application

Liver Cancer

Lung Cancer

Kidney Cancer

Bone Metastasis

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Tumor Ablation Market Key Players

Some of the key participating players in global tumor ablation market are

Medtronic plc

Angiodynamics, Inc.

Boston Scientific Corporation

Galil Medical, Inc.

EDAP TMS S.A.

Healthtronics, Inc.

Mermaid Medical, Inc.

Mesonix, Inc.

Neuwave Medical, Inc.

Sonacare Medical, LLC

To view Top Players, Segmentation and other Statistics of Tumor Ablation Industry, Get Sample Report @: https://reportsandinsights.com/sample-request/1267

About Reports and Insights:

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Neil Jonathan

1820 Avenue M, Brooklyn

NY 11230, United States

+1-(718) 312-8686

Find Us on LinkedIn: www.linkedin.com/company/report-and-insights/

View Latest Market Updates At: https://marketsresearchanalytics.com

[pancholir72-blog]

Global Tumor Ablation Market  Trends, Outlook 2017-2024

According to Data Bridge Market Research new Market report “Global Tumor Ablation Market, By Type (Tumor Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2022”, has accounted for USD 1.7 billion in 2015, and is expected to reach USD 2.9 billion by 2022, growing at a CAGR 8.2% during the forecast period 2016 to 2022.

Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market

The global tumor ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. However ablation technology can only be used to treat tumours with size less than 3cm, owing to the healthy tissue damage caused by it. With the advent of guidance mechanisms such as ultrasounds and MRI the accuracy of the treatment has increased significantly in the past 5 years.

Segmentation: Tumor Ablation Market Market 

·         The global tumor ablation market is segmented based on product types, cancer types, end-user and geography.

·         Based on end-user the global tumor ablation market is segmented into hospitals, oncology clinics and others. 

·         The global tumor ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation.

·         On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.

Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market

Geographical Segmentation: Tumor Ablation Market

Based on geography the global tumor ablation market is segmented into 5 geographical regions,

·         Asia-Pacific,

·         North America,

·         Europe,

·         South America and

·         rest of the world.

The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, Europe is expected to dominate the market with 36.7% market share, owing to the large incidence of cancer patients in this region coupled with good reimbursements.

Competitive Landscape: Tumor Ablation Market

The tumor  ablation market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumor  ablation market for global, Europe, North America, Asia Pacific and Rest of the World.

In 2015, Medtronic has dominated the global tumor  ablation market.

Some of the other key players operating in this market are

·         Galil Medical, Inc.,

·         Perseon Corporation,

·         NeuWave Medical, Inc.,

·         Koninklijke Philips N.V., INTIO Inc.,

·         Mermaid Medical A/S,

·         SonaCare Medical,

·         LLC,

·         DFINE, Inc.,

·         Misonix, Inc.,

·         BVM Medical Limited,

·         AngioDynamics, Inc.,

·         COMSOL Inc.,

·         Boston Scientific Corporation,

·         EDAP TMS S.A. and,

·         HealthTronics, Inc. among other companies.

Access Report: https://databridgemarketresearch.com/reports/global-tumour-ablation-market

About Us:  

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com